Clinical trial

Does a Migraine Medication Decrease Rotational Motion Sickness in People…

NCT00360282 · University of Pittsburgh, Other · Completed

Key facts

NCT number NCT00360282
Title Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
Official title Effect of Rizatriptan on Rotational Motion Sickness in Migraineurs
Lead sponsor University of Pittsburgh, Other
Collaborators Merck Sharp & Dohme LLC Industry
Status Completed
Study type Interventional
Conditions Migraine
Intervention type Drug, Other
Interventions Rizatriptan, Placebo
Enrollment 36
Start date Aug 1, 2006
Primary completion Jan 1, 2009
Completion Mar 1, 2010
First posted Aug 4, 2006
Last update posted Dec 8, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies